Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Lithuanian University of Health Sciences
With
Kaunas University of Technology
Age
25–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
25-65 years of age.
The patient, after reading the personal information form, confirms in writing his / her consent to participate in the study.
The study group includes patients with a primary open-angle normal intraocular pressure glaucoma diagnosis confirmed by an ophthalmologist (typical glaucomatous changes in the optic nerve disc and eye area, open angle of the anterior chamber, intraocular pressure in the diurnal curve with/without anti-glaucoma medication ≤ 21 mmHg) and IOP ≤ 21mmHg on study day with/without anti-glaucoma medication.
The control group includes healthy volunteers who do not suffer from glaucoma, acute or chronic uncompensated disease that may affect the results of the research, and according to age and anthropometric data correspond to the individuals of other research groups.
You may not be if
Patient's refusal to participate in biomedical research.
Persons younger than 25 years or older than 65 years.
A woman who may become pregnant, be pregnant or breastfeeding.
The patient is allergic or sensitive to local anesthetics.
Suffering from an eye disease that may distort the results of the study, if so decided by the examining physician.
Patients who have had orbital or eye trauma.
Patients who have undergone any eye surgery.
Patients with acute or chronic, but currently aggravated, respiratory system disease.
Patients with uncompensated cardiovascular diseases (II-III AV block or cardiogenic shock).
Patients with uncompensated diabetes.
Neurological diseases, mental illnesses identified in the anamnesis.
Clareo Health | R&D of Non-invasive Innovative Intracranial Waves Monitoring System for Diagnostics and Treatment Monitoring of Patients with Normal Tension Glaucoma
